insights_auto
Why is ONCY down 5.97%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
$0.40
arrow_downward
-5.97%(-0.025) 1D
$0.40
arrow_downward
-1.00% (-0.0040)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.42
High
$0.43
Low
$0.39
Mkt. cap
51.89M
Avg. vol.
1.29M
Volume
0.00
52-wk high
$1.30
52-wk low
$0.39
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.42
High
$0.43
Low
$0.39
Mkt. cap
51.89M
Avg. vol.
1.29M
Volume
0.00
52-wk high
$1.30
52-wk low
$0.39
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
Markets Media
·
32 minutes ago
NYSE Expands Network of Transfer Agents
조선일보
·
52 minutes ago
Anthropic to Raise 5 Trillion Won in Japan
Bloomberg.com
·
5 hours ago
Nasdaq Slide Clouds Asian Open, Oil Falls on Iran: Markets Wrap
markets.businessinsider.com
·
51 minutes ago
STARTRADER Spotlights ANTHUSD Pre-IPO CFD as Anthropic Files to List on Nasdaq
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com